Global E-Health Forum to Present Strategies, Solutions and Services

25 - 26 October 2010, Hamburg, Germany.
Healthcare systems all over the world are facing very similar challenges: demographic shifts, the impact of globalization and an increased burden of chronic diseases and expensive treatments, to mention some of the most important ones. The Global E-Health Forum will addresses these challenges. The first conference day at the Hamburg Chamber of Commerce will feature strategy and best practice presentation, workshops, discussion forums and an accompanying exhibition. The second day will be hosted by Asklepios Clinics. There, conference attendees may expect show cases, hands-on presentations and guided tours as well as a panel discussion titled "Connecting Competence for E-Health Services - What Customers Expect, What Healthcare Has to Deliver". The official reception for the international audience will take place at the U.S. Consulate General.

"Countries all over the world are facing manifold challenges regarding their healthcare delivery. Due to limited budgets and increasing demand for high-quality healthcare services, new cost-efficient, reliable and interconnected systems need to be developed", explains Ljubisav Matejevic, founder and director of the Global E-Health Forum. "This is the reason why after three Baltic Conferences on E-Health (2007-2009), we have decided to found the Global E-Health Forum," continues Ljubisav Matejevic. "E-health, meaning the application of information and communication technologies across the whole range of functions that affect the health sector, can make an important contribution to ensure a high-quality healthcare service for all citizens now and in the future.”

In keynote presentations, speakers from the U.S., Europe and New Zealand will explain their e-health strategies. Harry Reynolds, chairman of the National Committee on Vital and Health Statistics (NCVHS) and chairman of the Council for Affordable Quality Healthcare (CAQH) CORE Initiative will start this program session with his presentation titled "U.S. Health Reform: Significant Change, Varied Reaction, Opportunities Abound, and Outcome Uncertain".

The second program session will deal with best practices, for example presenting the hospital information system of Severance Cardiovascular Hospital in Seoul, South Korea. Other best practices featured will be a medical decision support system for general practitioners and interesting solutions regarding questions of quality management and process optimization.

The program will also include various breakout sessions with workshops and discussion forums where e.g. sustainable telemedicine services will be presented.

The organizers of the Global E-Health Forum - European Health Telematics Association (EHTEL), Hamburg Chamber of Commerce and IBM - have identified in Asklepios an excellent cooperation partner. Recognized as one of the most innovative leading hospital chains (the group oversees over 100 institutions, almost 40 day clinics, around 22,000 beds and 36,000 staff in Germany, Europe and the USA), Asklepios takes care of over one million patients every year. At Asklepios Clinics in Hamburg, attendees may expect more best practice solutions and hands-on experience. However, another important part will be the "services session" meaning the patients' and consumers' perspective / patient-centric e-health services. Uwe Poettgen, CIO of the Asklepios Group, will introduce this topic with a presentation entitled "Connecting Competence for E-Health Services - What Customers Expect, What Healthcare Has to Deliver".

The primary aim of the English-language conference is to provide a cross-sector forum for approximately 200 representatives from hospitals and clinics, governments, health insurance organizations, service providers and the media. Policymakers, users, suppliers and implementation managers will have the opportunity to exchange views and experiences among all those involved in health management. The impact of globalization on healthcare systems and services will be discussed as well as the resulting requirements regarding interconnectivity, interoperability and standardization as well as the need for cross border co-operation.

Among the supporters of this year's conference are the European Association of Healthcare IT Managers, Koch-Mechnikov-Forum, German Hospital Society, U.S. Commercial Service, Finpro, Business Institute (Croatia), and FOM University of Applied Sciences.

For further information and registration, please visit:
http://www.global-ehealth-forum.com

Most Popular Now

Sanofi builds focus on rare blood disorders and ca…

Some of the most serious unmet patient needs today are in the field of hematology. Rare blood disorders and blood-related cancers continue to be a major focus of research...

Novartis rises to second place in 2018 Access to M…

Novartis ranked second in the 2018 Access to Medicine Index (ATMi), up from 3rd place in 2016, in recognition of its long-standing efforts to improve worldwide access to ...

FDA approves first treatment for Lambert-Eaton mya…

The U.S. Food and Drug Administration today approved Firdapse (amifampridine) tablets for the treatment of Lambert-Eaton myasthenic syndrome (LEMS) in adults. LEMS is a r...

FDA approves new treatment for patients with acute…

The U.S. Food and Drug Administration today approved Daurismo (glasdegib) tablets to be used in combination with low-dose cytarabine (LDAC), a type of chemotherapy, for t...

FDA grants breakthrough device designation to arti…

Bayer announced today that the U.S. Food and Drug Administration (FDA) granted Breakthrough Device Designation to the Artificial Intelligence Software for Chronic Thrombo...

U.S. FDA approves Larotrectinib, the first TRK inh…

The U.S. Food and Drug Administration (FDA) has approved larotrectinib, the first oral TRK inhibitor, under the brand name Vitrakvi®. The approval is for the treatment of...

Pfizer reaches a global agreement with AbbVie

Pfizer Inc. (NYSE:PFE) has signed licensing agreements with AbbVie, resolving all global intellectual property matters for Pfizer's proposed adalimumab biosimilar. Under ...

Merck and Pfizer provide update on avelumab in pla…

Merck and Pfizer Inc. (NYSE: PFE) today announced that the Phase III JAVELIN Ovarian 200 trial evaluating avelumab* alone or in combination with pegylated liposomal doxor...

New study reveals probiotics do not help children …

Probiotics are a multibillion-dollar industry with marketing claims of being an effective treatment for a multitude of ailments, including diarrhea. However, findings fro...

Bristol-Myers Squibb awards "Golden Tickets…

Bristol-Myers Squibb Company (NYSE: BMY) and LabCentral, an innovative, shared laboratory space designed as a launchpad for life-sciences and biotech startups, today anno...

Alcon to highlight its vision, strategy and benefi…

Alcon, the eye care division of Novartis, will today hold its first Capital Markets Day for investors and analysts in relation to the previously-announced intention of No...

GSK reaches agreement to acquire TESARO, an oncolo…

GlaxoSmithKline plc (LSE/NYSE: GSK) and TESARO Inc (NASDAQ: TSRO) announced that the Companies have entered into a definitive agreement pursuant to which GSK will acquire...